Advertisement

Diagnosis and Management of the Critically Ill Adult Patient with Hyperglycemic Hyperosmolar State

      Abstract

      Background

      Hyperglycemic hyperosmolar state is a life-threatening complication of diabetes mellitus. Therefore, it is important for emergency physicians to be aware of this unique diagnosis and treatment considerations.

      Objective

      This manuscript reviews the emergency department evaluation and management of the adult patient with hyperglycemic hyperosmolar state.

      Discussion

      Hyperglycemic hyperosmolar state is diagnosed by an elevated glucose, elevated serum osmolality, minimal or absent ketones, and a neurologic abnormality, most commonly altered mental status. Treatment involves fluid resuscitation and correction of electrolyte abnormalities. It is important to monitor these patients closely to avoid overcorrection of osmolality, sodium, and other electrolytes. These patients are critically ill and generally require admission to an intensive care unit.

      Conclusions

      Hyperglycemic hyperosmolar state is associated with significant morbidity and mortality. It is important for clinicians to be aware of the current evidence regarding the diagnosis, management, and disposition of these patients.

      Keywords

      To read this article in full you will need to make a payment

      References

        • Scott A.R.
        Management of hyperosmolar hyperglycaemic state in adults with diabetes.
        Diabet Med. 2015; 32: 714-724
        • Fayfman M.
        • Pasquel F.J.
        • Umpierrez G.E.
        Management of hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state.
        Med Clin North Am. 2017; 101: 587-606
        • Umpierrez G.E.
        • Kelly J.P.
        • Navarrete J.E.
        • Casals M.M.
        • Kitabchi A.E.
        Hyperglycemic crises in urban blacks.
        Arch Intern Med. 1997; 157: 669-675
        • Dhatariya K.K.
        • Vellanki P.
        Treatment of diabetic ketoacidosis (DKA)/hyperglycemic hyperosmolar state (HHS): novel advances in the management of hyperglycemic crises (UK versus USA).
        Curr Diab Rep. 2017; 17: 33
        • Umpierrez G.
        • Korytkowski M.
        Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia.
        Nat Rev Endocrinol. 2016; 12: 222-232
        • Karslioglu French E.
        • Donihi A.C.
        • Korytkowski M.T.
        Diabetic ketoacidosis and hyperosmolar hyperglycemic syndrome: review of acute decompensated diabetes in adult patients.
        BMJ. 2019; 365: l1114
        • Kitabchi A.E.
        • Umpierrez G.E.
        • Miles J.M.
        • Fisher J.N.
        Hyperglycemic crises in adult patients with diabetes.
        Diabetes Care. 2009; 32: 1335-1343
        • Rosenbloom A.L.
        Hyperglycemic hyperosmolar state: an emerging pediatric problem.
        J Pediatr. 2010; 156: 180-184
        • Zeitler P.
        • Haqq A.
        • Rosenbloom A.
        • Glaser N.
        • Drugs and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Societ
        Hyperglycemic hyperosmolar syndrome in children: pathophysiological considerations and suggested guidelines for treatment.
        J Pediatr. 2011; 158 (14.e1–2): 9-14
        • Ekpebegh C.O.
        • Longo-Mbenza B.
        • Akinrinmade A.
        • Blanco-Blanco E.
        • Badri M.
        • Levitt N.S.
        Hyperglycaemic crisis in the Eastern Cape province of South Africa: high mortality and association of hyperosmolar ketoacidosis with a new diagnosis of diabetes.
        S Afr Med J. 2010; 100: 822-826
        • Bassham B.
        • Estrada C.
        • Abramo T.
        Hyperglycemic hyperosmolar syndrome in the pediatric patient: a case report and review of the literature.
        Pediatr Emerg Care. 2012; 28: 699-702
        • Price A.
        • Losek J.
        • Jackson B.
        Hyperglycaemic hyperosmolar syndrome in children: patient characteristics, diagnostic delays and associated complications.
        J Paediatr Child Health. 2016; 52: 80-84
        • Pasquel F.J.
        • Umpierrez G.E.
        Hyperosmolar hyperglycemic state: a historic review of the clinical presentation, diagnosis, and treatment.
        Diabetes Care. 2014; 37: 3124-3131
        • Fadini G.P.
        • de Kreutzenberg S.V.
        • Rigato M.
        • et al.
        Characteristics and outcomes of the hyperglycemic hyperosmolar non-ketotic syndrome in a cohort of 51 consecutive cases at a single center.
        Diabetes Res Clin Pract. 2011; 94: 172-179
        • Bhowmick S.K.
        • Levens K.L.
        • Rettig K.R.
        Hyperosmolar hyperglycemic crisis: an acute life-threatening event in children and adolescents with type 2 diabetes mellitus.
        Endocr Pract. 2005; 11: 23-29
        • Milionis H.J.
        • Elisaf M.S.
        Therapeutic management of hyperglycaemic hyperosmolar syndrome.
        Expert Opin Pharmacother. 2005; 6: 1841-1849
        • Savage M.W.
        • Dhatariya K.K.
        • Kilvert A.
        • et al.
        Joint British Diabetes Societies guideline for the management of diabetic ketoacidosis.
        Diabet Med. 2011; 28: 508-515
        • Otieno C.F.
        • Kayima J.K.
        • Omonge E.O.
        • Oyoo G.O.
        Diabetic ketoacidosis: risk factors, mechanisms and management strategies in sub-Saharan Africa: a review.
        East Afr Med J. 2005; 82: S197-S203
        • Gosmanov A.R.
        • Gosmanova E.O.
        • Kitabchi A.E.
        • et al.
        Hyperglycemic crises: diabetic ketoacidosis (DKA), and hyperglycemic hyperosmolar state (HHS).
        in: Feingold KR Anawalt B Boyce A Endotext. MDText.com, Inc, South Dartmouth, MA2000 (Copyright © 2000–2020, MDText.com, Inc.)
        • Wachtel T.J.
        • Silliman R.A.
        • Lamberton P.
        Prognostic factors in the diabetic hyperosmolar state.
        J Am Geriatr Soc. 1987; 35: 737-741
        • Wachtel T.J.
        • Tetu-Mouradjian L.M.
        • Goldman D.L.
        • Ellis S.E.
        • O'Sullivan P.S.
        Hyperosmolarity and acidosis in diabetes mellitus: a three-year experience in Rhode Island.
        J Gen Intern Med. 1991; 6: 495-502
        • Gerich J.E.
        • Martin M.M.
        • Recant L.
        Clinical and metabolic characteristics of hyperosmolar nonketotic coma.
        Diabetes. 1971; 20: 228-238
        • Chiasson J.L.
        • Aris-Jilwan N.
        • Bélanger R.
        • et al.
        Diagnosis and treatment of diabetic ketoacidosis and the hyperglycemic hyperosmolar state.
        CMAJ. 2003; 168: 859-866
        • Wachtel T.J.
        The diabetic hyperosmolar state.
        Clin Geriatr Med. 1990; 6: 797-806
        • Kitabchi A.E.
        • Wall B.M.
        Diabetic ketoacidosis.
        Med Clin North Am. 1995; 79: 9-37
      1. Implementation of treatment protocols in the Diabetes Control and Complications Trial.
        Diabetes Care. 1995; 18: 361-376
        • Chu C.H.
        • Lee J.K.
        • Lam H.C.
        • Lu C.C.
        Prognostic factors of hyperglycemic hyperosmolar nonketotic state.
        Chang Gung Med J. 2001; 24: 345-351
        • Randall L.
        • Begovic J.
        • Hudson M.
        • et al.
        Recurrent diabetic ketoacidosis in inner-city minority patients: behavioral, socioeconomic, and psychosocial factors.
        Diabetes Care. 2011; 34: 1891-1896
        • Lohiya S.
        • Kreisberg R.
        • Lohiya V.
        Recurrent diabetic ketoacidosis in two community teaching hospitals.
        Endocr Pract. 2013; 19: 829-833
        • Lorber D.
        Nonketotic hypertonicity in diabetes mellitus.
        Med Clin North Am. 1995; 79: 39-52
        • Ananth J.
        • Parameswaran S.
        • Gunatilake S.
        Side effects of atypical antipsychotic drugs.
        Curr Pharm Des. 2004; 10: 2219-2229
        • Tavakoli S.A.
        • Arguisola M.S.
        Diabetic ketoacidosis in a patient treated with olanzapine, valproic acid, and venlafaxine.
        South Med J. 2003; 96: 729-730
        • Wilson D.R.
        • D'Souza L.
        • Sarkar N.
        • Newton M.
        • Hammond C.
        New-onset diabetes and ketoacidosis with atypical antipsychotics.
        Schizophr Res. 2003; 59: 1-6
        • Ekpebegh C.
        • Longo-Mbenza B.
        Mortality in hyperglycemic crisis: a high association with infections and cerebrovascular disease.
        Minerva Endocrinol. 2013; 38: 187-193
        • Roefaro J.
        • Mukherjee S.M.
        Olanzapine-lnduced hyperglycemic nonketonic coma.
        Ann Pharmacother. 2001; 35: 300-302
        • Ben Salem C.
        • Fathallah N.
        • Hmouda H.
        • Bouraoui K.
        Drug-induced hypoglycaemia: an update.
        Drug Saf. 2011; 34: 21-45
        • Caro J.J.
        • Ward A.
        • Levinton C.
        • Robinson K.
        The risk of diabetes during olanzapine use compared with risperidone use: a retrospective database analysis.
        J Clin Psychiatry. 2002; 63: 1135-1139
        • Buse J.B.
        • Cavazzoni P.
        • Hornbuckle K.
        • Hutchins D.
        • Breier A.
        • Jovanovic L.
        A retrospective cohort study of diabetes mellitus and antipsychotic treatment in the United States.
        J Clin Epidemiol. 2003; 56: 164-170
        • Gianfrancesco F.
        • Grogg A.
        • Mahmoud R.
        • Wang R.H.
        • Meletiche D.
        Differential effects of antipsychotic agents on the risk of development of type 2 diabetes mellitus in patients with mood disorders.
        Clin Ther. 2003; 25: 1150-1171
        • Lipscombe L.L.
        • Austin P.C.
        • Alessi-Severini S.
        • et al.
        Atypical antipsychotics and hyperglycemic emergencies: multicentre, retrospective cohort study of administrative data.
        Schizophr Res. 2014; 154: 54-60
        • Uçok A.
        • Gaebel W.
        Side effects of atypical antipsychotics: a brief overview.
        World Psychiatry. 2008; 7: 58-62
        • Waldhäusl W.
        • Kleinberger G.
        • Korn A.
        • Dudczak R.
        • Bratusch-Marrain P.
        • Nowotny P.
        Severe hyperglycemia: effects of rehydration on endocrine derangements and blood glucose concentration.
        Diabetes. 1979; 28: 577-584
        • Chupin M.
        • Charbonnel B.
        • Chupin F.
        C-peptide blood levels in keto-acidosis and in hyperosmolar non-ketotic diabetic coma.
        Acta Diabetol Lat. 1981; 18: 123-128
        • Macaulay M.B.
        Hyperosmolar non-ketotic diabetes.
        Postgrad Med J. 1971; 47: 191-196
        • Kitabchi A.E.
        • Umpierrez G.E.
        • Murphy M.B.
        • et al.
        Management of hyperglycemic crises in patients with diabetes.
        Diabetes Care. 2001; 24: 131-153
        • Adrogué H.J.
        • Wilson H.
        • Boyd 3rd, A.E.
        • Suki W.N.
        • Eknoyan G.
        Plasma acid-base patterns in diabetic ketoacidosis.
        N Engl J Med. 1982; 307: 1603-1610
        • Bartoli E.
        • Bergamasco L.
        • Sainaghi P.P.
        • Guidetti F.
        • Castello L.
        An improved method to compute the solute and water derangements of hyperglycaemia.
        Eur J Appl Physiol. 2007; 102: 97-105
        • Braaten J.T.
        Hyperosmolar nonketotic diabetic coma: diagnosis and management.
        Geriatrics. 1987; 42 (92): 83-88
        • Rains J.L.
        • Jain S.K.
        Oxidative stress, insulin signaling, and diabetes.
        Free Radic Biol Med. 2011; 50: 567-575
        • Li J.
        • Huang M.
        • Shen X.
        The association of oxidative stress and pro-inflammatory cytokines in diabetic patients with hyperglycemic crisis.
        J Diabetes Complications. 2014; 28: 662-666
        • Stentz F.B.
        • Umpierrez G.E.
        • Cuervo R.
        • Kitabchi A.E.
        Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises.
        Diabetes. 2004; 53: 2079-2086
        • Arieff A.I.
        • Carroll H.J.
        Nonketotic hyperosmolar coma with hyperglycemia: clinical features, pathophysiology, renal function, acid-base balance, plasma-cerebrospinal fluid equilibria and the effects of therapy in 37 cases.
        Medicine (Baltimore). 1972; 51: 73-94
        • Delaney M.F.
        • Zisman A.
        • Kettyle W.M.
        Diabetic ketoacidosis and hyperglycemic hyperosmolar nonketotic syndrome.
        Endocrinol Metab Clin North Am. 2000; 29 (v): 683-705
        • Lapides J.
        • Bourne R.B.
        • Maclean L.R.
        Clinical signs of dehydration and extracellular fluid loss.
        JAMA. 1965; 191: 413-415
        • Kavouras S.A.
        Assessing hydration status.
        Curr Opin Clin Nutr Metab Care. 2002; 5: 519-524
        • Coller F.A.
        • Maddock W.G.
        A study of dehydration in humans.
        Ann Surg. 1935; 102: 947-960
        • Mange K.
        • Matsuura D.
        • Cizman B.
        • et al.
        Language guiding therapy: the case of dehydration versus volume depletion.
        Ann Intern Med. 1997; 127: 848-853
        • Bartoli E.
        • Bergamasco L.
        • Castello L.
        • Sainaghi P.P.
        Methods for the quantitative assessment of electrolyte disturbances in hyperglycaemia.
        Nutr Metab Cardiovasc Dis. 2009; 19: 67-74
        • Umpierrez G.
        • Freire A.X.
        Abdominal pain in patients with hyperglycemic crises.
        J Crit Care. 2002; 17: 63-67
        • Daugirdas J.T.
        • Kronfol N.O.
        • Tzamaloukas A.H.
        • Ing T.S.
        Hyperosmolar coma: cellular dehydration and the serum sodium concentration.
        Ann Intern Med. 1989; 110: 855-857
        • Baldrighi M.
        • Sainaghi P.P.
        • Bellan M.
        • Bartoli E.
        • Castello L.M.
        Hyperglycemic hyperosmolar state: a pragmatic approach to properly manage sodium derangements.
        Curr Diabetes Rev. 2018; 14: 534-541
        • Seldin D.W.
        • Tarail R.
        Effect of hypertonic solutions on metabolism and excretion of electrolytes.
        Am J Physiol. 1949; 159: 160-174
        • Hillier T.A.
        • Abbott R.D.
        • Barrett E.J.
        Hyponatremia: evaluating the correction factor for hyperglycemia.
        Am J Med. 1999; 106: 399-403
        • Katz M.A.
        Hyperglycemia-induced hyponatremia–calculation of expected serum sodium depression.
        N Engl J Med. 1973; 289: 843-844
        • Beigelman P.M.
        Potassium in severe diabetic ketoacidosis.
        Am J Med. 1973; 54: 419-420
        • Adrogué H.J.
        • Lederer E.D.
        • Suki W.N.
        • Eknoyan G.
        Determinants of plasma potassium levels in diabetic ketoacidosis.
        Medicine (Baltimore). 1986; 65: 163-172
        • Cokar O.
        • Aydin B.
        • Ozer F.
        Non-ketotic hyperglycaemia presenting as epilepsia partialis continua.
        Seizure. 2004; 13: 264-269
        • Raghavendra S.
        • Ashalatha R.
        • Thomas S.V.
        • Kesavadas C.
        Focal neuronal loss, reversible subcortical focal T2 hypointensity in seizures with a nonketotic hyperglycemic hyperosmolar state.
        Neuroradiology. 2007; 49: 299-305
        • O'Malley G.
        • Moran C.
        • Draman M.S.
        • et al.
        Central pontine myelinolysis complicating treatment of the hyperglycaemic hyperosmolar state.
        Ann Clin Biochem. 2008; 45: 440-443
        • Matz R.
        Management of the hyperosmolar hyperglycemic syndrome.
        Am Fam Physician. 1999; 60: 1468-1476
        • Self W.H.
        • Evans C.S.
        • Jenkins C.A.
        • et al.
        Clinical effects of balanced crystalloids vs saline in adults with diabetic ketoacidosis: a subgroup analysis of cluster randomized clinical trials.
        JAMA Netw Open. 2020; 3e2024596
        • Semler M.W.
        • Self W.H.
        • Wanderer J.P.
        • et al.
        Balanced crystalloids versus saline in critically ill adults.
        N Engl J Med. 2018; 378: 829-839
        • Adrogué H.J.
        • Madias N.E.
        Hypernatremia.
        N Engl J Med. 2000; 342: 1493-1499
        • Braun M.M.
        • Barstow C.H.
        • Pyzocha N.J.
        Diagnosis and management of sodium disorders: hyponatremia and hypernatremia.
        Am Fam Physician. 2015; 91: 299-307
        • Chauhan K.
        • Pattharanitima P.
        • Patel N.
        • et al.
        Rate of correction of hypernatremia and health outcomes in critically ill patients.
        Clin J Am Soc Nephrol. 2019; 14: 656-663
        • Kitabchi A.E.
        • Umpierrez G.E.
        • Murphy M.B.
        • et al.
        Hyperglycemic crises in diabetes.
        Diabetes Care. 2004; 27: S94-102
        • Cruz-Caudillo J.C.
        • Sabatini S.
        Diabetic hyperosmolar syndrome.
        Nephron. 1995; 69: 201-210
        • Long B.
        • Willis G.C.
        • Lentz S.
        • Koyfman A.
        • Gottlieb M.
        Evaluation and management of the critically ill adult with diabetic ketoacidosis.
        J Emerg Med. 2020; 59: 371-383
        • Goyal N.
        • Miller J.B.
        • Sankey S.S.
        • Mossallam U.
        Utility of initial bolus insulin in the treatment of diabetic ketoacidosis.
        J Emerg Med. 2010; 38: 422-427
        • Sterns R.H.
        • Riggs J.E.
        • Schochet Jr., S.S.
        Osmotic demyelination syndrome following correction of hyponatremia.
        N Engl J Med. 1986; 314: 1535-1542
        • Singh T.D.
        • Fugate J.E.
        • Rabinstein A.A.
        Central pontine and extrapontine myelinolysis: a systematic review.
        Eur J Neurol. 2014; 21: 1443-1450
        • Kumar S.
        • Fowler M.
        • Gonzalez-Toledo E.
        • Jaffe S.L.
        Central pontine myelinolysis, an update.
        Neurol Res. 2006; 28: 360-366
        • Ho M.L.
        • Rojas R.
        • Eisenberg R.L.
        Cerebral edema.
        AJR Am J Roentgenol. 2012; 199: W258-W273
        • Graff-Radford J.
        • Fugate J.E.
        • Kaufmann T.J.
        • Mandrekar J.N.
        • Rabinstein A.A.
        Clinical and radiologic correlations of central pontine myelinolysis syndrome.
        Mayo Clin Proc. 2011; 86: 1063-1067
        • Long B.
        • Koyfman A.
        • Gottlieb M.
        An evidence-based narrative review of the emergency department evaluation and management of rhabdomyolysis.
        Am J Emerg Med. 2019; 37: 518-523